Could be just shorter's doing their thing again after a bit of a run up. The new web site looks ok to me. Shows a big emphasis on photocosmetics. Interesting their models are consistent with the target market although I don't see consumers confined to just that market, particularly when 2nd and 3rd products are released. Problem now is I don't see commercial catalysts in the short term although happy to be surprised. Until the half year next year we might get two newsletters prior to xmas and maybe some trial updates. If the financial results are good and we get 12-17 yo on board we may launch into a really good second half with decent updates on XP, stroke, neutracthal and other indications. Not stressing, not overly happy but still patient it will pay off. Great for those in NEU and PME watching a different progression at the moment. merry xmas
CUV Price at posting:
$16.30 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)